Correlation of modified Shimada classification with MYCN and 1p36 status detected by fluorescence in situ hybridization in neuroblastoma
- PMID: 17213019
- DOI: 10.1016/j.cancergencyto.2006.10.005
Correlation of modified Shimada classification with MYCN and 1p36 status detected by fluorescence in situ hybridization in neuroblastoma
Abstract
Neuroblastoma (NB) is a childhood cancer derived from neural crest cells, with a highly variable clinical course and biologic behavior. NB cells harbor complex genetic changes. Also, MYCN amplification is a well-known molecular marker for aggressive progression, and deletion of the short arm of chromosome 1 is frequently observed in NB. The aim of this study was to investigate the correlation between genetic markers and prognostic morphological parameters to address the biology and underlying the clinical complexity of NB. Therefore, we performed fluorescence in situ hybridization analyses of chromosome band 1p36 and MYCN in a series of tumors from 43 cases classified according to the recommendation of International Neuroblastoma Pathology Committee (modification of Shimada classification). The correlations of MYCN amplification status and two distinct types of 1p36 alterations (deletion and imbalance) with Shimada classification and histologic prognostic factors were statistically analyzed. Amplification of MYCN and 1p36 deletion was present in 14 (32.6%) and 18 (41.9%) cases, respectively. Sixteen cases (37.2%) displayed a favorable histology, while 27 (62.8%) had an unfavorable histology. The 1p36 deletion was found to be an independent predictor of unfavorable histology by multivariate analysis (logistic regression test, P = 0.03), but the 1p36 imbalance did not show any significance. Both 1p36 deletion and MYCN amplification showed significant correlation with undifferentiated tumors (chi-square test, P = 0.002 and 0.03, respectively). Highly significant correlation was found between the higher mitotic karyorrhectic index (MKI) and MYCN amplification (chi-square test, P < 0.001), whereas neither 1p36 deletion nor 1p36 imbalance significantly correlated with a higher MKI (chi-square test, P > 0.05). We conclude that 1p36 deletion may be a reliable parameter in determining unfavorable histology and predicting prognosis in NB. Further studies with prognostic data are needed to highlight its clinical significance.
Similar articles
-
Association of MYCN amplification and 1p deletion in neuroblastomas with high tumor vascularity.Appl Immunohistochem Mol Morphol. 2007 Jun;15(2):181-6. doi: 10.1097/01.pai.0000210418.38246.58. Appl Immunohistochem Mol Morphol. 2007. PMID: 17525631
-
FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma.Med Pediatr Oncol. 2003 Jul;41(1):30-5. doi: 10.1002/mpo.10313. Med Pediatr Oncol. 2003. PMID: 12764740
-
Detection of MYCN amplification and chromosome 1p36 loss in neuroblastoma by cDNA microarray comparative genomic hybridization.Mol Diagn. 2004;8(2):93-100. doi: 10.1007/BF03260051. Mol Diagn. 2004. PMID: 15527323
-
Relationship between histopathological features, MYCN amplification, and prognosis: a UKCCSG study. United Kingdom Children Cancer Study Group.Med Pediatr Oncol. 2001 Jan;36(1):169-76. doi: 10.1002/1096-911X(20010101)36:1<169::AID-MPO1041>3.0.CO;2-U. Med Pediatr Oncol. 2001. PMID: 11464876 Review.
-
Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p.J Mol Diagn. 2000 Feb;2(1):37-46. doi: 10.1016/S1525-1578(10)60613-7. J Mol Diagn. 2000. PMID: 11272900 Free PMC article. Review.
Cited by
-
Expression of BARD1 β Isoform in Selected Pediatric Tumors.Genes (Basel). 2021 Jan 26;12(2):168. doi: 10.3390/genes12020168. Genes (Basel). 2021. PMID: 33530592 Free PMC article.
-
Clinicopathological significance of vasculogenic mimicry and fetal hemoglobin expression in peripheral neuroblastic tumors in children.Am J Transl Res. 2023 Jul 15;15(7):4687-4698. eCollection 2023. Am J Transl Res. 2023. PMID: 37560203 Free PMC article.
-
CT-Based Radiomics Signature With Machine Learning Predicts MYCN Amplification in Pediatric Abdominal Neuroblastoma.Front Oncol. 2021 May 24;11:687884. doi: 10.3389/fonc.2021.687884. eCollection 2021. Front Oncol. 2021. PMID: 34109133 Free PMC article.
-
p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance.Front Oncol. 2012 Nov 28;2:173. doi: 10.3389/fonc.2012.00173. eCollection 2012. Front Oncol. 2012. PMID: 23226679 Free PMC article.
-
Genetics of congenital solid tumors.Rom J Morphol Embryol. 2020 Oct-Dec;61(4):1039-1049. doi: 10.47162/RJME.61.4.06. Rom J Morphol Embryol. 2020. PMID: 34171053 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical